헤일리온(HLN)는 NYSE에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $9.28 (-0.85%), 시가총액 $41.28B, PER (주가수익비율) 18.64, 52주 최저~최고 $8.72 ~ $11.41.
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Pa
헤일리온의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
헤일리온의 현재 주가는 $9.28 (-0.85%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
헤일리온의 시가총액은 약 $41.28B입니다. PER은 18.64입니다.
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin